In this Introduction to ClinicalTrials.gov, we will review a brief history of CT.gov including its original intent and the relevant laws, policies, guidance, best practices, and advocacy groups that have shaped CT.gov into its present form.
This session will explore the ways in which QUALITY is different from COMPLIANCE.
Join this session to gain an understanding of how FDA drug and device requirements apply to research activities.
This session will explore the importance and evolution of clinical site accreditation. Learn about best practices, standards, regulatory differences, and how these factors align to bring quality and consistency to clinical trial sites.
This session will provide an overview of the required documentation for clinical research participants in HealthLink, UW Health’s electronic health record.
Learn more about theranostics and how theranostics-related research is conducted.
Learn more about the current state of clinical research at UW–Madison, as well as what's on the horizon for the clinical research community in 2023.
Explore best practices and considerations for fiscal planning and management of clinical trials at UW–Madison, including budgeting tools, fees to include, and negotiation tips.
As a follow-up to our 'UW Clinical Research Update' session in January, this will be an open question and answer forum.
Learn tips for what to do before, during, and after an FDA audit of a clinical trial.
Learn what bias is, see examples of how it shows up in healthcare, the language we use, and clinical trials. Also, learn a few strategies to move towards a more race-conscious approach that will address our unconscious biases.
Engage with leaders within the UW clinical research community at this open Q+A ‘Research Forum’. This is an opportunity to ask questions about clinical research-related topics such as the IRB, informatics, and clinical trials.
